SEC 13F Intelligence

Managers / Q2 2021 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$512M
Q2 2021
Positions
49
Filings on Record
30
2019–present window
Filed
Aug 10, 2021
original filing

Summary

Sivik Global Healthcare LLC reported $512M in U.S.-listed holdings across 49 positions for Q2 2021.

Its largest position, XBI, represents 2.6% of the portfolio.

Compared with Q1 2021, the fund opened 15 new positions and exited 13.

Portfolio Metrics

Turnover
+17.5%
vs prior filed quarter
Top-10 Concentration
+20.7%
share of reported value
Largest Position
+2.6%
Spdr S P Biotech Etf
New / Exited
15 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 52.6%Other: 43.8%ETP: 2.6%ADR: 1.0%
  • Common Stock · 52.6% · $269M
  • Other · 43.8% · $224M
  • ETP · 2.6% · $14M
  • ADR · 1.0% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SPDR S&P 500 ETF TrustNEW+5.0K5.0K+$214M$214M
XBISPDR S&P Biotech ETFNEW+100.0K100.0K+$14M$14M
LLYEli Lilly & CoNEW+40.0K40.0K+$9M$9M
BMYBristol-Myers Squibb CoNEW+85.0K85.0K+$6M$6M
MRKMerck & Co IncNEW+60.0K60.0K+$5M$5M
ILMNIllumina IncNEW+8.0K8.0K+$4M$4M
CAHCardinal Health IncNEW+65.0K65.0K+$4M$4M
Hologic IncNEW+50.0K50.0K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P Biotech ETFhistory →Cash Securities2.64%$14M100.0K
2HUMHumana Inchistory →Cash Securities2.16%$11M25.0K
3UNHUnitedHealth Group Inchistory →Cash Securities2.15%$11M27.5K
4UHSUniversal Health Services Inchistory →Cash Securities2.14%$11M75.0K
5CNCCentene Corphistory →Cash Securities1.99%$10M140.0K
6MOHMolina Healthcare Inchistory →Cash Securities1.98%$10M40.0K
7THCTenet Healthcare Corphistory →Cash Securities1.96%$10M150.0K
8MDTMedtronic PLChistory →Cash Securities1.94%$10M80.0K
9ZBHZimmer Biomet Holdings Inchistory →Cash Securities1.88%$10M60.0K
10Charles River Laboratories InCash Securities1.81%$9M25.0K
11LLYEli Lilly & Cohistory →Cash Securities1.79%$9M40.0K
12JNJJohnson & Johnsonhistory →Cash Securities1.77%$9M55.0K
13AVTRAvantor Inchistory →Cash Securities1.73%$9M250.0K
14IQVIQVIA Holdings Inchistory →Cash Securities1.66%$8M35.0K
15BSXBoston Scientific Corphistory →Cash Securities1.59%$8M190.0K
16DHRDanaher Corphistory →Cash Securities1.57%$8M30.0K
17MCKMcKesson Corphistory →Cash Securities1.49%$8M40.0K
18Catalent IncCash Securities1.48%$8M70.0K
19BRKRBruker Corphistory →Cash Securities1.41%$7M95.0K
20BIIBBiogen Inchistory →Cash Securities1.35%$7M20.0K
21WATWaters Corphistory →Cash Securities1.35%$7M20.0K
22Laboratory Corp of America HoCash Securities1.35%$7M25.0K
23SYKStryker Corphistory →Cash Securities1.27%$6M25.0K
24HCAHCA Healthcare Inchistory →Cash Securities1.21%$6M30.0K
25ABTAbbott Laboratorieshistory →Cash Securities1.13%$6M50.0K
26CORAmerisourceBergen Corphistory →Cash Securities1.12%$6M50.0K
27BMYBristol-Myers Squibb Cohistory →Cash Securities1.11%$6M85.0K
28BAXBaxter International Inchistory →Cash Securities1.10%$6M70.0K
29EHCEncompass Health Corphistory →Cash Securities1.07%$5M70.0K
30MRKMerck & Co IncCash Securities0.91%$5M60.0K
31BMRNBioMarin Pharmaceutical IncCash Securities0.90%$5M55.0K
32AAgilent Technologies IncCash Securities0.87%$4M30.0K
33GMEDGlobus Medical IncCash Securities0.83%$4M55.0K
34HRCHill-Rom Holdings IncCash Securities0.78%$4M35.0K
35ILMNIllumina IncCash Securities0.74%$4M8.0K
36CAHCardinal Health IncCash Securities0.72%$4M65.0K
37Hologic IncCash Securities0.65%$3M50.0K
38SNYSanofiCash Securities0.62%$3M60.0K
39Seagen IncCash Securities0.62%$3M20.0K
40Mirati Therapeutics IncCash Securities0.47%$2M15.0K
41Turning Point Therapeutics InCash Securities0.46%$2M30.0K
42ABBVAbbVie IncCash Securities0.44%$2M20.0K
43QGENQIAGEN NVCash Securities0.43%$2M45.0K
44S24Select Medical Holdings CorpCash Securities0.41%$2M50.0K
45SRPTSarepta Therapeutics IncCash Securities0.38%$2M25.0K
46ARGXArgenx SECash Securities0.35%$2M6.0K
47SANASana Biotechnology IncCash Securities0.24%$1M63.4K
48Eargo IncCash Securities0.17%$870,00021.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.